LIMN Stock Analysis: Buy, Sell, or Hold?
LIMN - Liminatus Pharma, Inc. Class A Common Stock
$0.10
0.00 (0.88%)
β²
5d:
-7.12%
30d:
-10.28%
90d:
-49.53%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jun 30, 2026
0d
Get Alerted When LIMN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
π HOLD: LIMN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
π HOLD: LIMN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: LIMN is currently trading at $0.10, which is considered slightly low relative to its 30-day fair value range of $0.10 to $0.13.
Technical Outlook: Technically, LIMN is in a strong downtrend. Immediate support is located at $0.10, while resistance sits at $0.13.
Market Sentiment: LIMN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LIMN is in a strong downtrend. Immediate support is located at $0.10, while resistance sits at $0.13.
Market Sentiment: LIMN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.10 -
$0.13
Company Quality Score
44/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- CAUTION: 5-day price weakness (-7.1%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.10 -
$0.13
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.10
Resistance Level
$0.13
Current Trend
Strong Downtrend
Technical data as of
Jul 31, 2026
Fundamental Context
Share & Embed Analysis
Last updated: August 03, 2026 1:01 AM ET
Data refreshes hourly during market hours. Next update: 2:01 AM
Data refreshes hourly during market hours. Next update: 2:01 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LIMN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$87 | 53 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$196 | 47 HOLD |
|
VRTX
Vertex Pharmaceuticals I⦠|
BUY
34 analysts |
$557 | 49 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical⦠|
STRONG BUY
17 analysts |
$86 | 47 HOLD |